The first patient has been treated in a first-in-human clinical trial investigating the safety and efficacy of the CXLens system, a quantitative corneal cross-linking, or qCXL, technology for ...

Please provide your email address to receive an email when new articles are posted on . Cross-linking is a resource-intensive procedure. Designating cross-linking “champions” will help improve and ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

Patients in Somerset with keratoconus, an eye condition that causes blurred vision and sensitivity to light, can now access ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for ...